Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
OPERATING EXPENSES
Research and development	$ 1,464,177	$ 1,134,132	$ 4,530,448	$ 3,628,622
General and administrative	643,358	1,408,231	2,139,392	2,536,050
Total operating expenses	2,107,535	2,542,363	6,669,840	6,164,672
LOSS FROM OPERATIONS	(2,107,535)	(2,542,363)	(6,669,840)	(6,164,672)
OTHER INCOME (EXPENSE)
Interest income	2,021	9,264	6,267	15,265
Interest expense	(2,516)	(44,937)	(83,718)	(49,068)
Loss on disposal of property and equipment			(2,026)	0
Gain on warrant settlement		614,494	0	614,494
Loss on issuance of Series A preferred stock for accounts payable - related party			0	(142,669)
Change in fair value of derivative liability		(6,119,762)		(5,845,313)
Other (expense) income	(495)	(5,540,941)	(79,477)	(5,407,291)
LOSS BEFORE INCOME TAX PROVISION	(2,108,030)	(8,083,304)	(6,749,317)	(11,571,963)
INCOME TAX PROVISION	0	0	0	0
NET LOSS	$ (2,108,030)	$ (8,083,304)	$ (6,749,317)	$ (11,571,963)
NET LOSS PER COMMON SHARE
Net loss per common share- basic and diluted	$ (0.19)	$ (1.24)	$ (0.63)	$ (2.45)
Weighted average common shares outstanding
Weighted average common shares outstanding - basic and diluted	10,953,052	6,518,077	10,700,405	4,732,514